Korro Bio Statistics

Total Valuation

Korro Bio has a market cap or net worth of $66.11 million. The enterprise value is $8.28 million.

Market Cap	66.11M
Enterprise Value	8.28M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Korro Bio has 9.42 million shares outstanding. The number of shares has increased by 18.78% in one year.

Current Share Class	9.42M
Shares Outstanding	9.42M
Shares Change (YoY)	+18.78%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	6.39%
Owned by Institutions (%)	71.62%
Float	5.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.94
Forward PS	56.36
PB Ratio	0.67
P/TBV Ratio	0.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.71, with a Debt / Equity ratio of 0.45.

Current Ratio	6.71
Quick Ratio	6.37
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.46% and return on invested capital (ROIC) is -32.35%.

Return on Equity (ROE)	-63.46%
Return on Assets (ROA)	-29.16%
Return on Invested Capital (ROIC)	-32.35%
Return on Capital Employed (ROCE)	-64.32%
Revenue Per Employee	$70,875
Profits Per Employee	-$850,163
Employee Count	104
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, Korro Bio has paid $104,000 in taxes.

Income Tax	104,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.82% in the last 52 weeks. The beta is 2.86, so Korro Bio's price volatility has been higher than the market average.

Beta (5Y)	2.86
52-Week Price Change	-81.82%
50-Day Moving Average	29.84
200-Day Moving Average	21.43
Relative Strength Index (RSI)	27.09
Average Volume (20 Days)	1,142,936

Short Selling Information

The latest short interest is 1.44 million, so 15.30% of the outstanding shares have been sold short.

Short Interest	1.44M
Short Previous Month	1.16M
Short % of Shares Out	15.30%
Short % of Float	24.94%
Short Ratio (days to cover)	1.93

Income Statement

In the last 12 months, Korro Bio had revenue of $7.37 million and -$88.42 million in losses. Loss per share was -$9.42.

Revenue	7.37M
Gross Profit	46,000
Operating Income	-94.50M
Pretax Income	-88.31M
Net Income	-88.42M
EBITDA	-89.62M
EBIT	-94.50M
Loss Per Share	-$9.42

Full Income Statement

Balance Sheet

The company has $92.48 million in cash and $44.67 million in debt, giving a net cash position of $57.83 million or $6.14 per share.

Cash & Cash Equivalents	92.48M
Total Debt	44.67M
Net Cash	57.83M
Net Cash Per Share	$6.14
Equity (Book Value)	99.03M
Book Value Per Share	10.54
Working Capital	83.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.35 million and capital expenditures -$1.89 million, giving a free cash flow of -$70.24 million.

Operating Cash Flow	-68.35M
Capital Expenditures	-1.89M
Free Cash Flow	-70.24M
FCF Per Share	-$7.46

Full Cash Flow Statement

Margins

Gross Margin	0.62%
Operating Margin	-1,282.04%
Pretax Margin	-1,198.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.78%
Shareholder Yield	-18.78%
Earnings Yield	-133.74%
FCF Yield	-106.25%

Analyst Forecast

The average price target for Korro Bio is $74.17, which is 956.55% higher than the current price. The consensus rating is "Buy".

Price Target	$74.17
Price Target Difference	956.55%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	112.00%
EPS Growth Forecast (5Y)	0.82%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Korro Bio has an Altman Z-Score of -1.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.5
Piotroski F-Score	1